Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL1043848 | 0.97 | TSHR (0.43) | TSHRALDH1A1TDP1MAPK1LMNA | |
| Methyl Alcohol SCHEMBL1172803 | 0.88 | TSHR (0.50) | TSHRALDH1A1TDP1 | |
| Propylene Glycol SCHEMBL8343721 | 0.84 | TDP1 (0.50) | TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL30636 | 0.82 | TSHR (0.56) | TSHRALDH1A1TDP1 | |
| SCHEMBL15156443 | 0.80 | TSHR (0.43) | TSHRALDH1A1TDP1 | |
| Alcohol SCHEMBL3258906 | 0.79 | TSHR (0.47) | TSHRALDH1A1TDP1 | |
| Glycerin SCHEMBL4057689 | 0.79 | ALDH1A1 (0.45) | TSHRALDH1A1TDP1LMNA | |
| SCHEMBL9619269 | 0.78 | TSHR (0.53) | TSHRALDH1A1TDP1 | |
| Water SCHEMBL22581155 | 0.78 | TSHR (0.53) | TSHRALDH1A1TDP1 | |
| SCHEMBL22233969 | 0.78 | TSHR (0.53) | TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029715-B2 | Precursor compounds for providing retinoids of the vitamin A5 pathway and uses thereof | UNIVERSITY OF DEBRECEN (HU) | 2024-07-09 | — | — | US | disclosed |
| US-20190054056-A1 | PRECURSOR COMPOUNDS FOR PROVIDING RETINOIDS OF THE VATAMIN A5 PATHWAY AND USES THEREOF | UNIVERSITY OF DEBRECEN (HU) | 2019-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029715-B2 | Precursor compounds for providing retinoids of the vitamin A5 pathway and uses thereof | RXRA, RXRG, RARA | TSHR 299/4885ALDH1A1 1015/4885TDP1 4840/4885 |
| US-20190054056-A1 | PRECURSOR COMPOUNDS FOR PROVIDING RETINOIDS OF THE VATAMIN A5 PATHWAY AND USES THEREOF | RXRA, RARA, RXRG | TSHR 177/4885ALDH1A1 1454/4885TDP1 4768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.